Trogocytosis of MHC-I/Peptide Complexes Derived from Tumors and Infected Cells Enhances Dendritic Cell Cross-Priming and Promotes Adaptive T Cell Responses

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Zhang, Qian Jin ^a   Li, Xiao Lin ^a   Wang, David ^a   Huang, Xiao Cong ^a   Mathis, J Michael ^a   Duan, Wei Ming ^a   Knight, David ^a   Shi, Runhua ^a   Glass, Jonathan ^a   Zhang, Dong Qing ^b   Eisenbach, Lea ^c   Jefferies, Wilfred A ^d  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ADAPTATION; ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GAMMA RADIATION; HUMAN; IMMUNOLOGY; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NEOPLASM; RADIATION EXPOSURE; T LYMPHOCYTE;

ADAPTATION, BIOLOGICAL; ANIMALS; ANTIGEN-PRESENTING CELLS; CROSS-PRIMING; DENDRITIC CELLS; GAMMA RAYS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; NEOPLASMS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 58149243026     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003097     Document Type: Article

References (43)

1. Jefferies WA, Kolaitis G, Gabathuler R, (1993) IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides. J Immunol 151: 2974-2985.
2. Gabathuler R, Reid G, Kolaitis G, Driscoll J, Jefferies WA, (1994) Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J Exp Med 180: 1415-1425.
3. Seliger B, Maeurer MJ, Ferrone S, (1997) TAP off-tumors on. Immunol Today 18: 292-299.
4. Seliger B, Maeurer MJ, Ferrone S, (2000) Antigen-processing machinery breakdown and tumor growth. Immunol Today 21: 455-464.
5. Garcia-Lora A, Algarra I, Garrido F, (2003) MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 195: 346-355.
6. Plaksin D, Gelber C, Feldman M, Eisenbach L, (1988) Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene. Proc Natl Acad Sci U S A 85: 4463-4467.
7. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, et al.(1995) Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol 25: 1374-1384.
8. Kallfelz M, Jung D, Hilmes C, Knuth A, Jaeger E, et al.(1999) Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer. Int J Cancer 81: 125-133.
9. Johnsen AK, Templeton DJ, Sy M, Harding CV, (1999) Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J Immunol 163: 4224-4231.
10. Alimonti J, Zhang QJ, Gabathuler R, Reid G, Chen SS, et al.(2000) TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nat Biotechnol 18: 515-520.
11. Lou Y, Vitalis TZ, Basha G, Cai B, Chen SS, et al.(2005) Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res 65: 7926-7933.
12. Evans M, Borysiewicz LK, Evans AS, Rowe M, Jones M, et al.(2001) Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6. J Immunol 167: 5420-5428.
13. Agrawal S, Reemtsma K, Bagiella E, Oluwole SF, Braunstein NS, (2004) Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma. Cell Immunol 228: 130-137.
14. Zhang QJ, Seipp RP, Chen SS, Vitalis TZ, Li XL, et al.(2007) TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma. Int J Cancer.
15. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, et al.(1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264: 961-965.
16. Sigal LJ, Crotty S, Andino R, Rock KL, (1999) Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398: 77-80.
17. Heath WR, Carbone FR, (2001) Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19: 47-64.
18. Lizee G, Basha G, Tiong J, Julien JP, Tian M, et al.(2003) Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat Immunol 4: 1065-1073.
19. Heath WR, Carbone FR, (2001) Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 1: 126-134.
20. Herrera OB, Golshayan D, Tibbott R, Salcido Ochoa F, James MJ, et al.(2004) A novel pathway of alloantigen presentation by dendritic cells. J Immunol 173: 4828-4837.
21. Anderson K, Cresswell P, Gammon M, Hermes J, Williamson A, et al.(1991) Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J Exp Med 174: 489-492.
22. Momburg F, Hammerling GJ, (1998) Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. Adv Immunol 68: 191-256.
23. Bacik I, Cox JH, Anderson R, Yewdell JW, Bennink JR, (1994) TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. J Immunol 152: 381-387.
24. Hudrisier D, Joly E, (2002) Plasma membrane nibbling: all lymphocytes do it, but why? ELSO Gazette 9: 1-5.
25. Vitalis TZ, Zhang QJ, Alimonti J, Chen SS, Basha G, et al.(2005) Using the TAP component of the antigen-processing machinery as a molecular adjuvant. PLoS Pathog 1: e36.
26. Ronchetti A, Rovere P, Iezzi G, Galati G, Heltai S, et al.(1999) Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J Immunol 163: 130-136.
27. Dai J, Liu B, Caudill MM, Zheng H, Qiao Y, et al.(2003) Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory. Cancer Immun 3: 1.
28. Hudrisier D, Riond J, Garidou L, Duthoit C, Joly E, (2005) T cell activation correlates with an increased proportion of antigen among the materials acquired from target cells. Eur J Immunol 35: 2284-2294.
29. Bullock TN, Colella TA, Engelhard VH, (2000) The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice. J Immunol 164: 2354-2361.
30. Bullock TN, Mullins DW, Engelhard VH, (2003) Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells. J Immunol 170: 1822-1829.
31. Allen TM, Vogel TU, Fuller DH, Mothe BR, Steffen S, et al.(2000) Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J Immunol 164: 4968-4978.
32. Hoffmann TK, Arsov C, Schirlau K, Bas M, Friebe-Hoffmann U, et al.(2006) T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx. Int J Cancer 118: 1984-1991.
33. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, et al.(2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7: 1306-1312.
34. Li Z, Srivastava PK, (1994) A critical contemplation on the role of heat shock proteins in transfer of antigenic peptides during antigen presentation. Behring Inst Mitt pp. 37-47.
35. Li Z, Dai J, Zheng H, Liu B, Caudill M, (2002) An integrated view of the roles and mechanisms of heat shock protein gp96-peptide complex in eliciting immune response. Front Biosci 7: d731-751.
36. Noessner E, Gastpar R, Milani V, Brandl A, Hutzler PJ, et al.(2002) Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J Immunol 169: 5424-5432.
37. Ueda G, Tamura Y, Hirai I, Kamiguchi K, Ichimiya S, et al.(2004) Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity. Cancer Sci 95: 248-253.
38. Zhang QJ, Chen SS, Saari CA, Massuci MG, Tufaro F, et al.(2000) Evidence of selective processing of immunodominant epitopes in virally infected cells. J Immunol 164: 4513-4521.
39. Levitsky HI, Lazenby A, Hayashi RJ, Pardoll DM, (1994) In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression. J Exp Med 179: 1215-1224.
40. Chiang EY, Henson M, Stroynowski I, (2003) Correction of defects responsible for impaired Qa-2 class Ib MHC expression on melanoma cells protects mice from tumor growth. J Immunol 170: 4515-4523.
41. Gabathuler R, Alimonti J, Zhang QJ, Kolaitis G, Reid G, et al.(1998) Surrogate antigen processing mediated by TAP-dependent antigenic peptide secretion. J Cell Biol 140: 17-27.
42. Spiliotis ET, Manley H, Osorio M, Zuniga MC, Edidin M, (2000) Selective export of MHC class I molecules from the ER after their dissociation from TAP. Immunity 13: 841-851.
43. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al.(1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.